The Cooper Companies, Inc. (ETR:CP60)
Germany · Delayed Price · Currency is EUR | Market Cap | 9.30B -21.8% |
| Revenue (ttm) | 3.68B +4.7% |
| Net Income | 495.76M +39.8% |
| EPS | 2.53 +42.4% |
| Shares Out | n/a |
| PE Ratio | 18.76 |
| Forward PE | 11.98 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 163 |
| Open | 50.25 |
| Previous Close | 49.95 |
| Day's Range | 49.46 - 50.29 |
| 52-Week Range | 44.51 - 66.58 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 9, 2026 |
About The Cooper Companies
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cor... [Read more]
Financial Performance
In fiscal year 2025, The Cooper Companies's revenue was $4.09 billion, an increase of 5.06% compared to the previous year's $3.90 billion. Earnings were $374.90 million, a decrease of -4.44%.
Financial numbers in USD Financial StatementsNews
The Cooper Companies (NASDAQ: COO) Scrutinized Over U.S. Channel Inventory Reductions Driving Stock Sharply Lower -- HBSS
SAN FRANCISCO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- On September 10, 2026, investors in The Cooper Companies, Inc. (NASDAQ: COO) saw the price of their shares trade down $9.31 (-14.6%) after the company ...
CooperCompanies Unveils Accelerated CooperVision Innovation Strategy at The Vision Centre Opening
The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye Care The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye Care
Jana urges Cooper to replace CEO, explore asset sales after performance setbacks
Activist investor Jana Partners on Friday urged Cooper Companies to launch an external search for a new CEO and consider asset sales, arguing recent missteps have hurt investor confidence and weighe...
Activist Calls for Cooper Cos. to Seek New CEO.
Cooper Cos. stock rises as activist investor Jana Partners calls for the company to search for a new CEO and sell a key business segment.
JANA Partners Sends Letter to Cooper Board of Directors
Calls for Board to Commence Immediate External CEO Search, Appoint New Board Chair and ExploreAsset Sales NEW YORK, Sept. 18, 2026 /PRNewswire/ -- JANA Partners ("JANA") today announced that it has se...
Jana Partners Pushes Contact-Lens Maker Cooper to Replace Its CEO
The medical-device manufacturer requires an urgent overhaul to address its “chronic underperformance,” the activist hedge fund's letter says.
Cooper Stock Dropped and Put Volume Soared Before Bad News. What Happened?
The medical devices maker took a 5% hit on its stock before two big pieces of news—a guidance cut and the decision not to sell its women's health business.
COO SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Cooper Companies
Cooper Companies' quarterly revenue came in roughly $30 million short of Wall Street's consensus and shares fell -- SueWallSt notifies investors of a pending investigation into the Company's SEC repor...
Barron's Got Cooper Wrong but the Contact-Lens Stock Now Looks Cheap
Cooper Cos. stock has fallen about 25% since Barron's recommended it, but a low valuation, aggressive share buybacks, and takeover potential bolster the bull case.
Cooper Cos. Stock Drops After Soft Outlook, News It Won't Seek Deal
Shares of Cooper Cos. are pacing the S&P 500's decliners Thursday after the maker of medical devices reported mixed results, issued soft guidance and wrapped up a strategic review without plans to see...
Thursday's First Moves: AEO, M & COO Sell Off After Earnings
American Eagle Outfitters (AEO) posted a "mixed bag" earnings report, according to George Tsilis, who explains why the clothing retailer company is seeing pressure from pinched U.S. consumers. Macy's ...
2 Reasons Cooper Companies Stock Is By Far the Worst in the S&P 500 Today
The contact lens maker just sprung a surprise no one saw coming.
TSMC, Cooper Cos., American Eagle, Oracle, and More Stocks That Explain Today's Market
Taiwan Semi posts record August revenue, but that fails to spark a rally in AI stocks.
The Cooper Companies Earnings Call Transcript: Q3 2026
Q3 results exceeded expectations with record free cash flow and a major tax benefit. CooperVision was impacted by U.S. inventory reductions, but underlying demand is solid, while CooperSurgical saw continued fertility growth. Strategic review ended with no sale, and focus shifts to organic growth and sales execution.
The Cooper Companies Earnings release: Q3 2026
The Cooper Companies released its Q3 2026 earnings on September 9, 2026, summarizing the period's financial results.
The Cooper Companies Quarterly report: Q3 2026
The Cooper Companies has published its Q3 2026 quarterly earnings report on September 9, 2026.
The Cooper Companies Slides: Q3 2026
The Cooper Companies has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on September 9, 2026.
CooperCompanies Announces Third Quarter 2026 Results
SAN RAMON, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July ...
CooperCompanies Completes Strategic Review, Increases Share Repurchase Authorization
Board Unanimously Concludes to Retain CooperSurgical Expands Share Repurchase Authorization from $2 billion to $3 billion Board Remains Open to All Value Options that Create Shareholder Value SAN RAM...
CooperCompanies Announces Release Date for Third Quarter 2026
SAN RAMON, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report third quarter 2026 financial results on Wedn...
CooperCompanies Releases 2025 Corporate Sustainability Report with Scope 3 Emissions Disclosure
SAN RAMON, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, released today its 2025 Corporate Sustainability Report. The report showcas...
Cooper Cos. Is One of Today's Top S&P 500 Stocks.
The medical device maker gave an update on its troubled CooperSurgical business segment that was music to Wall Street's ears.
The Cooper Companies Earnings Call Transcript: Q2 2026
Record Q2 revenue and EPS growth driven by strong performance in both CooperVision and CooperSurgical, despite Asia-Pac softness and a significant litigation charge. Strategic review of CooperSurgical is advancing, with robust interest and potential for increased share buybacks.
The Cooper Companies Earnings release: Q2 2026
The Cooper Companies released its Q2 2026 earnings on June 4, 2026, summarizing the period's financial results.